← Eichor
Study identifier: NCT04699292 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

International Prospective Registry on Local Treatment Approaches in MLS

Condition: Myxoid Liposarcoma  ·  Sponsor: The Netherlands Cancer Institute

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

This description comes directly from the study's public registry record.

Talk to the study team

Rick Haas, MD/PhD  ·  +31 20 512 9111  ·  r.haas@nki.nl

Jules Lansu, MD/PhD  ·  +31 20 512 9111  ·  j.lansu@nki.nl

Always discuss trial participation with your own doctor first.

Locations (1)

The Netherlands Cancer InstituteAmsterdam, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04699292